L
Lytix Biopharma AS
OSE:LYTIX
Lytix Biopharma AS
OSE:LYTIX
Price:
5.06
NOK
1.2%
Market Closed
Market Cap:
345.4m
NOK
P/S
Price to Sales
Price to Sales
32.1
Current
47.4
Median
6.5
Industry
Lower
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=32.1
Market Cap
/
345.4m NOK
Revenue
10.8m NOK
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
38.9
2-Years Forward
P/S
3.2
3-Years Forward
P/S
N/A
You don't have any saved screeners yet
